Alvotech: A Fast-Expanding Biosimilar Concern
Source: SeekingAlpha
2025-07-11 12:49:27 ET
Today, I put Alvotech ( ALVO ) in the spotlight for the first time. This overseas-based biosimilar concern is experiencing explosive sales growth. Despite this, the stock has fallen just over 30% since the beginning of June. The company just appointed a new CFO. Is this biosimilar-focused concern in the ' buy zone ' yet? An initial analysis follows below....
Read the full article on Seeking Alpha
For further details see:
Alvotech: A Fast-Expanding Biosimilar Concern
Alvotech
NASDAQ: ALVO
ALVO Trading
-6.23% G/L:
$3.01 Last:
679,105 Volume:
$3.23 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
